Brochure | January 20, 2026

Sterile Drug Product

Source: Curia
GettyImages-1187680243-biological-indicator-sterilization

Save time and reduce costs while confidently advancing your product through our integrated global network of aseptic manufacturing sites and technical experts. At Curia, every program is tailored to your needs, supported by a dedicated program manager and an experienced team of subject matter experts who guide you seamlessly from development through commercial launch.

Curia specializes in the development and manufacture of complex APIs, including generics, potent and cytotoxic compounds, highly viscous formulations, and controlled substances. From early clinical phases to full commercial scale, our capabilities span three state-of-the-art facilities worldwide, ensuring consistent quality, technical excellence, and reliable supply at every stage of your product’s lifecycle.

access the Brochure!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online